Treatment of Henoch-Schönlein Purpura in Pulmonary Hemorrhage

Pulmonary hemorrhage is a serious complication in patients with Henoch-Schönlein purpura. It demands prompt evaluation, exclusion of alternative causes, and a coordinated first-line treatment approach.

Clinical Scenario

When Henoch-Schönlein purpura is complicated by pulmonary hemorrhage, clinicians must first assess and exclude other possible causes before attributing the finding to the underlying vasculitis. Management requires a multidisciplinary team — including a pulmonologist — with assessment for ICU admission.

First-Line Treatment

The recommended first-line approach involves pulsed intravenous corticosteroid therapy followed by oral steroid. The full sequence, dosing guidance, and additional clinical details are contained in the complete structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

Assess to exclude other possible causes for pulmonary hemorrhage.

Patient should be managed with multidisciplinary team including pulmonologist with assessment for ICU admission.

Initial pulse corticosteroids therapy (in previously mentioned doses) followed by oral steroid are advised for the management of pulmonary hemorrhage.

View source ↗